Publications by authors named "David Decraene"

Claim this Profile
A
AKT delays the early-activated apoptotic pathway in UVB-irradiated keratinocytes via BAD translocation.
Sofie Claerhout, David Decraene, An Van Laethem, Sofie Van Kelst, Patrizia Agostinis

J Invest Dermatol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A low UVB dose, with the potential to trigger a protective p53-dependent gene program, increases the resilience of keratinocytes against future UVB insults.
David Decraene, Katrien Smaers, Daniel Maes, Mary Matsui, Lieve Declercq

J Invest Dermatol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKT status controls susceptibility of malignant keratinocytes to the early-activated and UVB-induced apoptotic pathway.
David Decraene, An Van Laethem, Patrizia Agostinis, Lucie De Peuter, Hugo Degreef

J Invest Dermatol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic superoxide dismutase/catalase mimetic (EUK-134) inhibits membrane-damage-induced activation of mitogen-activated protein kinase pathways and reduces p53 accumulation in ultraviolet B-exposed primary human keratinocytes.
David Decraene, Katrien Smaers, David Gan, Tom Mammone, Mary Matsui

J Invest Dermatol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-1-mediated AKT activation postpones the onset of ultraviolet B-induced apoptosis, providing more time for cyclobutane thymine dimer removal in primary human keratinocytes.
David Decraene, Patrizia Agostinis, Roger Bouillon, Hugo Degreef, Marjan Garmyn

J Biol Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis